Page 9 - மரபியல் நிறுவனம் ஆஃப் தி நோவர்த்திச் ஆராய்ச்சி அடித்தளம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from மரபியல் நிறுவனம் ஆஃப் தி நோவர்த்திச் ஆராய்ச்சி அடித்தளம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In மரபியல் நிறுவனம் ஆஃப் தி நோவர்த்திச் ஆராய்ச்சி அடித்தளம் Today - Breaking & Trending Today

SeqOnce Biosciences Announces AzureSeq RT-qPCR Assay to Detect SARS-CoV-2 E484K Variant of Concern


Press release content from PR Newswire. The AP news staff was not involved in its creation.
SeqOnce Biosciences Announces AzureSeq RT-qPCR Assay to Detect SARS-CoV-2 E484K Variant of Concern
March 10, 2021 GMT
(PRNewsfoto/SeqOnce Biosciences, Inc.)
PASADENA, Calif., March 10, 2021 /PRNewswire/ SeqOnce Biosciences, Inc., announced today the launch of its new AzureSeq One-Step Universal RT-qPCR kit for the detection of the novel coronavirus SARS-CoV-2 E484K variant. The AzureSeq One-Step Universal SARS-CoV-2 RT-qPCR E484K kit uses a single-tube reaction targeting the N1 nucleocapsid gene, both alleles of S gene E484K (G23012A), and includes RNaseP as a control. The assay uses common qPCR instruments with detection channels of FAM, HEX, Cy5, and ROX. Using RT-qPCR to detect the SARS-CoV-2 E484K variant is faster and allows far more samples to be screened, compared to sequencing. ....

Seqonce Biosciences , James Gilmore , Joe Dunham , Chris Angermayer , Research Use , Seqonce Biosciences Inc , Prnewswire Seqonce Biosciences Inc , Once Biosciences , Azureseq One Step Universal , Next Generation Sequencing , Severe Acute Respiratory Syndrome , Covid 19 Pandemic , Pr Newswire , Coronavirus Pandemic , Lung Disease , Diseases And Conditions , Infectious Diseases , ஜேம்ஸ் கில்மோர் , ஓஹோ டன்ஹாம் , கிறிஸ் அங்கேர்மயிர் , ஆராய்ச்சி பயன்பாடு , ஒரு முறை உயிர் அறிவியல் , அடுத்தது ஜெநரேஶந் வரிசைப்படுத்துதல் , கடுமையானது எடுப்போசை சுவாச நோய்க்குறி , நுரையீரல் நோய் , நோய்கள் மற்றும் நிபந்தனைகள் ,

Market Outlook: Fund manager beating 95% of peers shares top themes


Matt Moberg s DynaTech Fund has beaten 95% of its category peers over the past five years.
It looks for innovation leaders with superior management that benefit from new industry conditions.
He laid out four trends he sees shaping today s economy that are rich investment backdrops. 
There is no doubt that COVID-19 has brought a lot of loss to the world. But at the same time, it has helped to accelerate innovation across industries as it s forced people and businesses to adapt to more constricted environments than they were accustomed to.
Decades-long digital disruptions took place in just months with the development of innovative solutions, such as voice products and cloud software that supported business activity, teleworking, and learning from home.  ....

Matt Moberg , His Franklin Dynatech Fund , Franklin Templeton Equity Group , Moberg Dynatech Fund , Globalx Artificial Intelligence Technology , Matt Moberg Dynatech Fund , Dynatech Fund , Franklin Templeton , Equity Group , Franklin Dynatech Fund , Thermo Fisher Scientific , Globalx Artificial Intelligence , Bi Prime , Investing Advice , Investing Analysis , Investing Themes , Investment Themes , Artificial Intellgence , Gene Sequencing , E Commerce , Digital Disruption , Covid And Economy , Innovation Explained , Innovation For Growth , Jaqueline Ting Quesada , மேட் மொபெர்க் ,

Interaction between LDL cholesterol and PRS can predict risk of heart attack


Interaction between LDL cholesterol and PRS can predict risk of heart attack
Allelica, a leading genomics software company specializing in developing polygenic risk scores (PRS) for personalized medicine, today announced publication of a study in
Circulation (Vol. 143, Issue 10) showing that the effect of LDL cholesterol on a person s risk of having a heart attack depends on their genes.
Using Allelica s proprietary PRS analysis software, the data showed that combining information on an individual s genetic risk of heart attack with their LDL level helps determine those at most risk from heart attack, including those potentially in need of treatment with statins or PCSK9 inhibitors. ....

Giordano Bott , George Busby , Emily Henderson , Coronary Artery Disease , United Kingdom , Heart Attack , ஜியோர்டானோ பாட்டில் , ஜார்ஜ் பஸ்பி , எமிலி ஹென்டர்சன் , கரோனரி தமனி நோய் , ஒன்றுபட்டது கிஂக்டம் , இதயம் தாக்குதல் ,

The US Has a Covid 'Scariants' Problem. Here's How to Fix It

Researchers are racing to understand new versions of the coronavirus. But without scientific standards, too many mutants are getting the monster treatment. ....

Corona Virus , Covid 19 , Public Health , கொரோனா வைரஸ் , தடுப்பு மருந்துகள் , பொது ஆரோக்கியம் ,